Ligand validation:1FM4

DXC: (3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID

DXC is a Ligand Of Interest in 1FM4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1FM4_DXC_A_1001	45%	17%	0.138	0.87	2.17	1.44	11	7	0	0	100%	1
1FM4_DXC_A_1002	42%	18%	0.167	0.884	2.16	1.42	12	8	0	0	100%	1
4A83_DXC_A_1161	90%	60%	0.068	0.95	0.69	0.83	-	1	4	0	100%	1
4A84_DXC_A_1161	60%	44%	0.119	0.904	0.67	1.48	-	7	1	0	100%	1
4A81_DXC_A_1161	54%	40%	0.138	0.904	0.82	1.5	-	10	2	0	100%	1
6UAD_DXC_A_201	92%	20%	0.067	0.959	1.54	1.82	5	12	0	0	100%	1
1OS6_DXC_A_75	84%	17%	0.079	0.939	2.14	1.51	13	9	2	0	100%	1
4HAJ_DXC_A_75	81%	47%	0.1	0.952	0.97	1.08	1	4	2	0	100%	1
3O01_DXC_B_1	75%	44%	0.098	0.929	0.76	1.39	-	6	0	0	100%	1
4HB6_DXC_A_75	74%	49%	0.108	0.938	0.88	1.07	1	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.